Time difference in retrieving clinical information in Patient-overview Prostate Cancer compared to electronic health records

Figures & data

Figure 1. Graph in Patient-overview Prostate Cancer (PPC) with longitudinal overview of treatment effects including clinical assessment and Patient Reported Outcome Measures (PROM). Reprinted by permission of Taylor & Francis Ltd, http://www.tandfonline.com, on behalf of Acta Chirurgica Scandinavica Society. ‘Set-up and preliminary results from the Patient-overview Prostate Cancer. Longitudinal registration of treatment of advanced prostate cancer in the National Prostate Cancer Register of Sweden’, Franck Lissbrant et al. [8], Scandinavian Journal of Urology, copyright © Acta Chirurgica Scandinavica Society.

Table 1. Characteristics of study participants; health staff timed while retrieving clinical information about patients and filling out questionnaires.

Health staff	Electronic Health Record
	Melior	COSMIC	Total
	(n = 16)	(n = 8)	n (%)
Hospital
Sahlgrenska	16	0	16 (67)
St Göran	0	2	2 (8)
Växjö	0	6	6 (25)
Age, years
20–30	2	0	2 (8)
31–40	4	2	6 (25)
41–50	5	4	9 (38)
51–60	4	2	6 (25)
61–70	1	0	1 (4)
Experience of PPC, months
≤6	6	7	13 (54)
7–24	3	0	3 (13)
≥25	7	1	8 (33)
Profession
Oncologist	8	2	10 (42)
Urologist	0	6	6 (25)
Urology nurse	8	0	8 (33)
Gender
Woman	10	3	13 (54)
Male	6	5	11 (46)
Working experience, years
≤5	5	0	5 (21)
6–10	4	2	6 (25)
≥11	7	6	13 (54)

PPC, Patient-overview Prostate Cancer.

Table 2. Characteristics of patients. The study included clinical information on patients registered in two of the most commonly used Electronic Health Records (EHRs) in Sweden; Melior and COSMIC.

Patients	Electronic Health Record
	Melior	COSMIC	Total
	(n = 8)	(n = 16)	n (%)
Hospital
Sahlgrenska	8	0	8 (33)
St Göran	0	8	8 (33)
Växjö	0	8	8 (33)
Risk category at diagnosis
Low risk	0	3	3 (13)
Intermediate risk	2	1	3 (13)
High risk/locally advanced	4	4	8 (33)
Metastatic	2	8	10 (42)
Primary treatment
WW/AS	0	2	2 (8)
RT/RP	3	4	7 (29)
Hormonal treatment	5	10	15 (63)
Time, years from diagnosis to death
<3	0	8	8 (33)
4–9	6	3	9 (38)
>10	2	5	7 (29)

WW, watchful waiting; AS, Active surveillance; RT, Radiation therapy; RP, Radical prostatectomy.

Figure 2. Distribution of time to complete questionnaire, including mean time in minutes using Patient-overview Prostate Cancer, PPC (orange) = 8.4 (SD = 3.7); the electronic health care records; COSMIC (blue) = 21.7 (SD = 9.9), and Melior (yellow) = 25.6 (SD = 11.4).

Figure 3. System Usability Scale questions with results from 24 participants.

Franck Lissbrant I, Hjälm Eriksson M, Lambe M, et al. Set-up and preliminary results from the patient-overview prostate cancer. Longitudinal registration of treatment of advanced prostate cancer in the National Prostate Cancer Register of Sweden. Scand J Urol. 2020;54(3):227–234.

 PubMed Web of Science ®Google Scholar